Evidence map›Paper›PMID 42415223›Full record

ArticleCardio-oncology (London, England)2026

Burden of cardiovascular diseases in breast cancer survivors: a 9-year retrospective cohort study based on regional medical data in Inner Mongolia China.

Qiaorui Wen, Yunjing Zhang, Liying Qiao, Meng Qi, Ying Yan, Weiwei Kang, Guozhen Liu, Mingyuan Wang, Siyan Zhan, Yunfeng Xi and 1 more

Abstract read
In one paragraph

Article in Cardio-oncology (London, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Qiaorui WenDepartment of Epidemiology and Biostatistics, School of Public Health, Peking University Health Science Center, Beijing, 100191, China.
Yunjing ZhangDepartment of Epidemiology and Biostatistics, School of Public Health, Peking University Health Science Center, Beijing, 100191, China.
Liying QiaoInner Mongolia Integrative Center for Disease Control and Prevention, Hohhot, 010031, China.
Meng QiBreast Cancer Center, Key Laboratory of Carcinogenesis and Translational Research Ministry of Education, Peking University School of Oncology, Beijing Cancer Hospital & Institute, Beijing, 100142, China.
Ying YanBreast Cancer Center, Key Laboratory of Carcinogenesis and Translational Research Ministry of Education, Peking University School of Oncology, Beijing Cancer Hospital & Institute, Beijing, 100142, China.
Weiwei KangInner Mongolia Integrative Center for Disease Control and Prevention, Hohhot, 010031, China.
Guozhen LiuPeking University Health Information Technology, Beijing, 100080, China.
Mingyuan WangPeking University Health Information Technology, Beijing, 100080, China.
Siyan ZhanDepartment of Epidemiology and Biostatistics, School of Public Health, Peking University Health Science Center, Beijing, 100191, China.
Yunfeng XiInner Mongolia Integrative Center for Disease Control and Prevention, Hohhot, 010031, China. xiyunfeng210@163.com.
Shengfeng WangDepartment of Epidemiology and Biostatistics, School of Public Health, Peking University Health Science Center, Beijing, 100191, China. shengfeng1984@126.com.

Funding

Capital's Funds for Health Improvement and Research 2024-1G-4251National Key Research and Development Program of China 2022YFC3602901, 2023YFC2507200National Natural Science Foundation of China 82173616, 72342015, 82330107
6 · The paper itself

Abstract

backgroundBreast cancer (BC) and cardiovascular diseases (CVD) shared many risk factors. Hitherto no studies revealing the burden of CVD and its subtypes in mainland Chinese BC patients exist. This study aimed to describe the incidence, prognosis and economic burden of CVD among BC survivors in Inner Mongolia.

methodsThis retrospective cohort study was conducted during 2012-2021, using data from the Inner Mongolia Regional Health Information Platform. BC patients were identified using diagnosis characters and ICD-10 code, and followed-up till new-onset CVD, death, or March 2021. New-onset CVD was documented by hospitalization, outpatient or medication records, and categorized into 12 subtypes. The incidence density, mortality density and medical costs were calculated. Subgroup analyses were also conducted by BC therapy status, nationality, GDP level and CVD subtypes.

resultsIn 29 516 BC patients included, the mean age was 52.03 ± 11.02, 16.55% were Mongolian. After 3.59 ± 2.34 years follow-up, we documented 12 527 new-onset CVD cases. The incidence density of CVD was 184.44 per 1000 person-years. Hypertension, arrhythmia, ischemic heart disease were the most common subtypes, with incidence density of 97.26, 79.80, and 53.90 per 1000 person-years. The incidence density peaked in the first year, especially the first three months, and then decreased gradually. BC patients with new-onset CVD had higher mortality density (33.41 vs. 19.63 per 1000 person-years), and bear higher expenses burden of average annual costs for outpatients (2349.20 vs. 2319.08 CNY) than those without. Patients residing in lower GDP areas had higher all-cause mortality density (35.37 vs. 31.45 per 1000 person-years), but higher average annual for hospitalization (18770.60 vs. 15827.69 CNY) than their counterpart. As for CVD subtypes, BC patients with heart failure and arrhythmia showed the top 2 highest mortality density and economic burden.

conclusionsAmong BC survivors in Inner Mongolia, hypertension and arrhythmia were the most common CVD subtypes, especially in the first three-month after BC diagnosis. Those with arrhythmia, heart failure, or from lower-GDP areas showed poorer prognosis. Results highlighted the urgent need for cardio-protective strategies for BC patients, especially at the first three-month post-diagnosis, for those from economically disadvantaged regions, targeting hypertension, arrhythmia and heart failure.

Indexed as

Breast cancerCardiovascular diseasesIncidenceInner MongoliaMortality

Identifiers

PMID42415223
PMCPMC13643984

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.